Our technique described below offers a reproducible, cost-effective approach for no-touch saphenous vein harvesting that can be adopted by well-trained surgical teams. The hybrid no-touch technique, ...
Introduction: Saphenous vein graft (SVG) failure remains a key limitation in coronary artery bypass grafting (CABG). The no-touch harvesting technique aims to improve graft durability by preserving ...
- Patients treated with Symvess were observed to have high levels of patency, 100% limb salvage, and zero cases of conduit infection - DURHAM, N.C., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc.
- Patients treated with Symvess were observed to have high levels of patency, 100% limb salvage, and zero cases of conduit infection - "Vascular complications of medical or surgical procedures aren't ...
The endoscopic vessel harvesting system market is witnessing a transformative phase, driven by growing healthcare demands and a rising preference for minimally invasive surgical techniques. These ...
‘No-touch’ vein harvesting significantly reduces the risk of graft failure up to three years after coronary artery bypass surgery compared with conventionally harvested vein grafts, finds a study from ...
RALEIGH, N.C. — Nearly 70 percent of heart-bypass surgeries in the United States use a small incision in the leg to harvest a vein for grafting into the heart, but the method now appears to result in ...
When I first analyzed Humacyte in October 2022, its stock was trading at ~$4.65 a share and prospects looked encouraging for its then dubbed human acellular vessel (HAV) platform candidates. The ...
Background: Since 2000, we have been grafting the right coronary artery system (RCAs) using the proximal portion of the right internal thoracic artery (RITA) as the inflow of the saphenous vein graft ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results